Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Trends in pathology malpractice claims.
Troxel DB.
Am J Surg Pathol. 2012 Jan;36(1):e1-5.
Related citations
Error occurred: cannot get document summary
Intact Percutaneous Excision (IPEX) for Definitive Diagnosis of High-Risk Breast Lesions.
Whitworth PW.
Ann Surg Oncol. 2011 Oct;18(11):3095. Epub 2011 Sep 9.
The mRNA expression of DAP3 in human breast cancer: correlation with clinicopathological parameters.
Wazir U, Jiang WG, Sharma AK, Mokbel K.
Anticancer Res. 2012 Feb;32(2):671-4.
Evaluation of breast cancer susceptibility loci on 2q35, 3p24, 17q23 and FGFR2 genes in Taiwanese women with breast cancer.
Lin CY, Ho CM, Bau DT, Yang SF, Liu SH, Lin PH, Lin TH, Tien N, Shih MC, Lu JJ.
Anticancer Res. 2012 Feb;32(2):475-82.
Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion.
Wu ZS, Wang CQ, Xiang R, Liu X, Ye S, Yang XQ, Zhang GH, Xu XC, Zhu T, Wu Q.
BMC Cancer. 2012 Feb 1;12:51.
Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer.
Wu QW, She HQ, Liang J, Huang YF, Yang QM, Yang QL, Zhang ZM.
BMC Cancer. 2012 Jan 27;12:47. doi: 10.1186/1471-2407-12-47.
The cyclin-like protein Spy1/RINGO promotes mammary transformation and is elevated in human breast cancer.
Al Sorkhy M, Ferraiuolo RM, Jalili E, Malysa A, Fratiloiu AR, Sloane BF, Porter LA.
BMC Cancer. 2012 Jan 26;12:45.
Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancer.
Mieog JS, de Kruijf EM, Bastiaannet E, Kuppen PJ, Sajet A, de Craen AJ, Smit VT, van de Velde CJ, Liefers GJ.
BMC Cancer. 2012 Jan 26;12:42. doi: 10.1186/1471-2407-12-42.
Understanding recent trends in incidence of invasive breast cancer in Norway: age-period-cohort analysis based on registry data on mammography screening and hormone treatment use.
Weedon-Fekjær H, Bakken K, Vatten LJ, Tretli S.
BMJ. 2012 Jan 30;344:e299. doi: 10.1136/bmj.e299.
The rise and fall of breast cancer rates.
Michels KB.
BMJ. 2012 Jan 30;344:d8003. doi: 10.1136/bmj.d8003. No abstract available.
Clinical significance of CD151 overexpression in subtypes of invasive breast cancer.
Kwon MJ, Park S, Choi JY, Oh E, Kim YJ, Park YH, Cho EY, Kwon MJ, Nam SJ, Im YH, Shin YK, Choi YL.
Br J Cancer. 2012 Feb 28;106(5):923-30. doi: 10.1038/bjc.2012.11. Epub 2012 Jan 31.
Relationship between breast cancer risk factors and mammographic breast density in the Fernald Community Cohort.
Yaghjyan L, Mahoney MC, Succop P, Wones R, Buckholz J, Pinney SM.
Br J Cancer. 2012 Feb 28;106(5):996-1003. doi: 10.1038/bjc.2012.1. Epub 2012 Jan 26.
15. Cancers attributable to reproductive factors in the UK in 2010.
Parkin DM.
Br J Cancer. 2011 Dec 6;105 Suppl 2:S73-6. doi: 10.1038/bjc.2011.488. No abstract available.
10. Cancers attributable to exposure to hormones in the UK in 2010.
Br J Cancer. 2011 Dec 6;105 Suppl 2:S42-8. doi: 10.1038/bjc.2011.483. No abstract available.
9. Cancers attributable to inadequate physical exercise in the UK in 2010.
Br J Cancer. 2011 Dec 6;105 Suppl 2:S38-41. doi: 10.1038/bjc.2011.482. No abstract available.
Comprehensive ultrasound diagnosis for intraductal spread of primary breast cancer.
Nakashima K, Moriya T.
Breast Cancer. 2012 Jan 31. [Epub ahead of print]
Harms of screening mammography for breast cancer in Japanese women.
Kasahara Y, Kawai M, Tsuji I, Tohno E, Yokoe T, Irahara M, Tangoku A, Ohuchi N.
Breast Cancer. 2012 Jan 27. [Epub ahead of print]
Do we need biomarkers to predict the benefit of adding adjuvant taxanes for treatment of breast cancer?
Pérez-García J, Cortés J.
Breast Cancer Res. 2012 Jan 31;14(1):104. [Epub ahead of print]
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on